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Abstract 
Uteroglobin, a progesterone-binding secretory protein, was shown to bind retinoic acid and retinol in a non-saturable manner, at least up to 
concentrations of retinoids of 20 PM. Binding is increased about IO-fold by previous reduction of uteroglobin with 10 mM dithothreitol and it is 
not affected by previous saturation of the progesterone binding site, suggesting different binding sites for the steroid and the retinoids. The results 
are discussed in relation to a possible physiological role for this protein. 
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1. Introduction 
Uteroglobin (UG) is a small secretory protein com- 
posed of two identical subunits held together by disulfide 
bridges which was first isolated from the rabbit endomet- 
rium where its gene is transcriptionally activated by pro- 
gesterone in early pregnancy (see [1,2] for reviews). UG 
is also synthesized in other tissues under the control of 
different steroid hormones: glucocorticoids in lung [3,4], 
estrogens in the oviduct [5] and androgens in the epidi- 
dymis [6]. The protein appears to be widely distributed 
among mammals. In addition to species of Lagomorpha 
[7], UG is found in humans [8,9], rat [lO,l 11, mouse and 
dog [12]. In the latter species the protein has been called 
CC10 (for Clara cell 10 kDa protein). 
While the mechanisms of the expression of the UG/ 
CC10 gene have been extensively studied in recent years 
[ 11,13-l 71 the physiological function of UG remains elu- 
sive. Rat CC10 binds polychlorinated biphenyl deriva- 
tives [lo]. Rabbit UG seems to have immunosuppressive 
properties by inhibiting phospholipase A, [2] and also 
possesses a well-studied progesterone binding ability 
[l&20]. None of these activities have been conclusively 
related to a physiological role. Searching for other possi- 
ble properties of UG, we have found that this protein is 
capable of binding both vitamin A and retinoic acid. 
2. Materials and methods 
[11,12-‘Hlretinoic acid @H]RA; 50.6 Ci/mmol) was obtained from 
New England Nuclear-DuPont. [ 11,12-‘HIvitamin A ([3H]retinol; 60 
Ci/mmol) was from Amersham International. All trans-retinoic acid 
(RA), vitamin A (retinol) and progesterone were obtained from Sigma. 
Purity of both labelled and unlabelled retinoids was assessed by HPLC 
on a Hypersil ODS column [21]. 
Uterine fluid from pseudopregnant rabbits was obtained by perfu- 
sion of the uterine lumen with phosphate-buffered saline, pH 7.5 (PBS) 
[22]. 1.5 ml of uterine perfusate was incubated for 1.5 h at 0°C with 
*Corresponding author. Fax: (34) (1) 397 47 99. 
1.5 @Zi of either [3H]RA or [SH]retinol and then analyzed on a Sephadex 
G-100 column (1.5 x 47 cm) equilibrated with PBS. Fractions (1.3 ml) 
were assayed for protein content (A,,,) and radioactivity. The UG peak 
was concentrated by lyophilization, incubated again with 0.5 PCi of the 
corresponding [3H]retinoid and rapidly passed through a Sephadex 
G-25 column (5 ml of bed volume) equilibrated with 25 mM ammonium 
acetate, pH 4.8. Fractions containing protein were pooled and applied 
to a CM-cellulose column (0.9 x 3 cm) which was developed with an 
ammonium acetate gradient [22]. Protein and radioactivity were deter- 
mined in the fractions as described above. All the steps were carried out 
at 04°C under subdued light and all solutions were de-aerated under 
vacuum and stored under N,. 
To study the parameters of the binding of retinoids to UG, protein- 
bound and free ligands were separated either by gel filtration or by 
dextran-coated charcoal (DCC) [18,23]. In gel filtration experiments, 
small portions of uterine fluid (0.2 ml, containing 80 pg of UG) were 
incubated with 0.5 &i of radioactive retinoids and the radioactivity 
bound to UG was analyzed on a small Sephadex G-100 column 
(0.9 x 25 cm). In other experiments, homogeneous UG (30 pg in 0.1 ml 
of PBS) was incubated with 0.3 ,&i of radioactive ligands. Free ligands 
were absorbed by adding 30 ~1 of DCC and leaving the samples at 0’ C 
for 5 min. After centrifugation, bound radioactivity was measured in 
the supernatants. When pertinent, unlabelled retinoids were added up 
to final concentrations of 20 PM. UG and uterine fluid were reduced 
with 10 mM dithiothreitol (DTT) for 15 min at 37°C [18]. 
Radioimmunoassay for UG was carried out as described previously 
[24]. SDS-polyacrylamide gel electrophoresis was carried out in slab 
gels [25], using an acrylamide gradient from 10 to 20%. Cellular RA and 
retinal-binding proteins (CRABP and CRBP, respectively) were puri- 
fied from rat testes and liver up to the step prior to Sephadex G-75 
chromatography [26]. 
3. Results 
When uterine fluid, incubated in the presence of 
[3H]RA, was analyzed on a Sephadex G-100 column, 
three peaks of radioactivity associated to proteins were 
observed (Fig. 1A). Peak I eluted at the void volume (V,) 
of the column and contained unknown proteins of high 
M, (inset, lane I). Peak II eluted with an apparent M, 
(inset, lane I). Peak II eluted with an apparent M, of 
approx. 65,000 and overlapped with a protein peak con- 
taining a major component of 65 kDa (inset, lane II) 
corresponding to serum albumin. Uterine fluid contains 
important amounts of serum albumin [271 and this protein 
binds RA and retinol in a non-saturable manner [28,29] 
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Fig. 1. Purification UG from rabbit uterine fluid. A and A’, Sephadex G-100 chromatography of uterine fluid incubated with [jH]RA or [‘Hlretinol, 
respectively. The inset shows a SDS-PAGE of material from peaks I, II and III (Coomassie blue staining). The arrowhead points to the UC band. 
Numbers to the left indicate the molecular mass (kDa) of the markers. B and B’, ion-exchange chromatography of the UC (peak III) obtained in 
A and A’, respectively. The inset shown the SDS-PAGE of the purified UC. 
which could account for the radioactivity in Peak II. 
Peak III overlapped with a protein peak that was identi- 
fied as UG on the basis of elution position [22], electro- 
phoretic behaviour (inset, lane III) and immunoreactiv- 
ity of the fractions in a specific radioimmunoassay (not 
shown). A duplicate sample of uterine fluid incubated 
with [3H]retinol produced a similar pattern (Fig. 1A’) 
although the radioactivity of peak II was considerably 
diminished, consistent with the low ability of serum albu- 
min to bind retinol (our unpublished observations). 
Peak III was further purified by ion-exchange chrom- 
atography to ensure that the observed binding was not 
due to a minor contaminant co-eluting with UG. Fig. 1B 
and B’ show that either RA or retinol were bound to 
homogeneous UG. 
Some parameters of the binding of both retinoids were 
then studied and the results are summarized in Table 1. 
Binding of either [3H]RA or [3H]retinol to UG was not 
displaced by a 500-fold in excess of the corresponding 
unlabelled retinoid, indicating a non-saturable binding 
at concentrations of 20 PM. This finding was confirmed 
by Scatchard plot analysis of the binding of the per- 
formed at different concentrations of the ligands (not 
shown). Higher concentrations of retinoids were not 
tested due to the low solubility of these compounds. 
Control experiments, performed in similar way but using 
CRABP and CRBP (see section 2), demonstrated that 
the binding of radioactive RA and retinol to these pro- 
teins could be completely displaced by an excess of unla- 
belled ligands (not shown). Therefore, our experimental 
conditions allowed for discrimination between saturable 
and non-saturable bindings. Binding of RA and retinol 
to UG was increased approx. lo-fold by previous treat- 
ment of the protein with DTT but was again unsaturable 
(Table 1). This enhancement of binding was specific for 
UG since the radioactivity peaks I and II were not 
affected by DTT as determined by gel filtration experi- 
ments (not shown). Since DTT also enhances the satura- 
Table 1 
Binding of labelled retinoids to UC 
Treatment RA Retinol 
Native UC 14.3 + 2.6 9.7 + 2.3 
Native UG + unlabelled retinoid 13.4 + 2.3 10.2 ? 2.4 
Native UG + progesterone 12.2 f 4.1 10.7 f 3.7 
Reduced UG 113.3 f 13.3 94.3 f 13 
Reduced UG + unlabelled retinoid 130 _+ 8.7 106.6 f 11 
Reduced UG + progesterone 135 f 8.2 103.3 f 13 
Values, expressed as cpmlpg of UG, are means f S.D. for three differ- 
ent experiments performed by the DCC method. 
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ble binding of progesterone to UG [l&20], we investi- 
gated whether the steroid and the retinoids might share 
the same binding site. Preincubation of either native or 
reduced UG with excess of progesterone (to saturate the 
progesterone-binding site) was without effect on the 
binding of either RA or retinol to UG (Table l), suggest- 
ing different binding sites for progesterone and retinoids. 
4. Discussion 
In this report we show that the progesterone-binding 
protein UG also binds RA and retinol. This binding was 
greatly enhanced by prior reduction of the protein with 
DTT, a treatment hat also increases the binding of pro- 
gesterone to UG [ 18,201. The effect of DTT on progester- 
one binding to UG appears to involve the disulfide bonds 
joining the two subunits of the protein [30]. In any case, 
reduction or blocking of these disulfide groups does not 
result in the dissociation of the two monomers of UG 
[22] although it produces conformational changes in the 
protein [31]. Although the UG binding site(s) for reti- 
noids remain to be characterized, they appear to be dif- 
ferent to that for progesterone since previous saturation 
of the progesterone binding site with an excess of steroid 
has no effect on the binding of retinoids. 
Several retinoid-binding proteins have been described 
so far in the secretions of the mammalian genital tract 
including four retinol-binding proteins isolated from the 
secretions of pig uterus [23] and two 18 kDa secretory 
polypeptides of the rat epididymis [32,33], all of them 
being regulated by sexual steroid hormones. UG, synthe- 
sized in several organs of the male and the female genital 
tract under the control of sexual steroid hormones, ap- 
pears to be another member of that class of retinoid- 
binding secretory proteins. The physiological function of 
these mentioned proteins remains to be elucidate but it 
is well established that retinoids play a crucial role in the 
normal function of the reproductive system [32,34] and 
in the development of the embryo [35]. The 18 kDa ep- 
idydimal protein has been tentatively implicated in the 
transport of RA to the spermatozoa [36] and, in relation 
to this, it is noteworthy that this protein associates to 
defined regions of the spermatozoa [36] as UG does [37]. 
On the other hand, given the number of ligands able 
to interact with UG (progesterone, polychlorinated 
biphenyls, RA and retinol), it is possible that UG could 
act as a multi-carrier protein for several compounds in 
different organs. 
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